Previous 10 | Next 10 |
CryoLife (NYSE: CRY ) is scheduled to announce Q4 earnings results on Wednesday, February 13th, after market close. More news on: CryoLife, Inc., Earnings news and commentary, , Healthcare stocks news, Read more ...
ATLANTA , Feb. 1, 2019 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2018 fourth quarter and year-end financial results will be released on Wednesday, February 13, 2019 after the marke...
NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Brown Forman Corporation (NYSE:BF.A), CryoLife, Inc. (NYSE:CRY), Aspen...
CryoLife, Inc. (CRY) Q3 2018 Results Earnings Conference Call November 01, 2018 08:30 AM ET Executives Lynn Lewis - IR, Gilmartin Group Pat MacKin - CEO Ashley Lee - CFO Analysts Jason Mills - Canaccord Genuity Frank Takkinen - Lake Street Capital Jeffrey Cohen - Ladenb...
CryoLife (NYSE: CRY ): Q3 Non-GAAP EPS of $0.08; GAAP EPS of $0.04. More news on: CryoLife, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
ATLANTA , Oct. 31, 2018 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY) , a leading cardiac and vascular surgery company focused on aortic disease, announced today its financial results for the third quarter ended September 30, 2018 . Third Quarter and Recent Business Highligh...
ADSW , AIG , ALL , AMGP , AMN , APA , AR , ATH , AWK , AXTI , BLDP , CACI , CDE , CF , CHDN , CLI , CMP , CMPR , CNO , CRY , ENSG , ESRT , ESRX , FARO , FISV , FIT , FORM , FOXF , FRAC , FRT , HBM , HCC , HGV , HPR , JBT , KRG , KW , LHCG , LSI , MAA ...
CRY expects 3Q18 revenue of ~$64.6M (+17% Y/Y) on non-GAAP basis driven by continuing strength in JOTEC (+32% Y/Y) on a non-GAAP basis, On-X (+36% Y/Y) and tissue processing (+15% Y/Y). More news on: CryoLife, Inc., Healthcare stocks news, Read more ...
ATLANTA , Oct. 15, 2018 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, in anticipation of discussions with its senior lenders regarding repricing its senior secured credit facility, today announced certain preliminary ...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. While the calendar rolls to October and investors can expect the invariable talk of...
News, Short Squeeze, Breakout and More Instantly...
CryoLife Announces Corporate Rebranding and Changes Name to Artivion Artivion to Host Investor & Analyst Day on March 23, 2022 PR Newswire ATLANTA , Jan. 18, 2022 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company f...
CryoLife to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum CryoLife to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum PR Newswire ATLANTA , N...
Image source: The Motley Fool. Cryolife Inc (NYSE: CRY) Q3 2021 Earnings Call Nov 4, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Cryolife Inc (CRY) Q3 2021 Earnings Call Transcript